157 related articles for article (PubMed ID: 25650788)
1. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers.
Tagami T; Matsui H; Yasunaga H
J Thromb Haemost; 2015 Apr; 13(4):686-8. PubMed ID: 25650788
[No Abstract] [Full Text] [Related]
2. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
Wada H; Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N
J Thromb Haemost; 2015 Apr; 13(4):684-5. PubMed ID: 25611679
[No Abstract] [Full Text] [Related]
3. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
Iba T
J Thromb Haemost; 2015 Apr; 13(4):682-3. PubMed ID: 25611174
[No Abstract] [Full Text] [Related]
4. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: reply.
Tagami T; Matsui H; Yasunaga H
J Thromb Haemost; 2015 Apr; 13(4):680-2. PubMed ID: 25530550
[No Abstract] [Full Text] [Related]
5. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment.
Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N; Wada H
J Thromb Haemost; 2015 Apr; 13(4):679-80. PubMed ID: 25528989
[No Abstract] [Full Text] [Related]
6. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic options for patients with sepsis and disseminated intravascular coagulation.
Iba T; Yamada A; Hashiguchi N; Nagaoka I
Pol Arch Med Wewn; 2014; 124(6):321-8. PubMed ID: 24732306
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
10. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Murao A; Kato T; Yamane T; Honda G; Eguchi Y
Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
[TBL] [Abstract][Full Text] [Related]
11. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
13. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
Eguchi Y; Yoshida T; Okabe H
Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
[No Abstract] [Full Text] [Related]
14. Treatment with Antithrombin or Thrombomodulin and Mortality from Heatstroke-Induced Disseminated Intravascular Coagulation: A Nationwide Observational Study.
Ohbe H; Isogai S; Jo T; Matsui H; Fushimi K; Yasunaga H
Semin Thromb Hemost; 2019 Nov; 45(8):760-766. PubMed ID: 31627216
[TBL] [Abstract][Full Text] [Related]
15. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trials for severe sepsis/DIC].
Kushimoto S
Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
[No Abstract] [Full Text] [Related]
18. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombin].
Iba T; Nakarai E
Rinsho Byori; 2011 Feb; Suppl 147():167-70. PubMed ID: 21761766
[No Abstract] [Full Text] [Related]
20. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
